What 3D BioFibR does

3D BioFibR is a Halifax, Nova Scotia-based biotechnology and advanced materials company founded in 2020 that commercializes a patented automated dry-spinning platform for producing biomimetic protein fibers at commercial scale. The company's flagship CollaFibR® product line consists of collagen fibers that closely replicate the structure, biomechanics, and biochemistry of natural collagen, with the company claiming over 1000x the throughput of competing technologies and first-mover status in commercial-scale collagen fiber spinning. The same platform has been used to produce recombinant spider silk (SpidrFibR™ — claimed to be five times stronger than steel), fibrin, and chitosan, indicating applicability across multiple network-forming biopolymers. The company is led by CEO Kevin Sullivan (23+ years of biotech leadership and a prior TSX IPO) and CSO Dr. John Frampton (Tier II Canada Research Chair at Dalhousie University, 40+ publications, 2 patents).

3D BioFibR generates revenue through three channels: direct e-commerce sales of two catalog SKUs (μCollaFibR™ Additive for Bioinks and Hydrogels, and CollaFibR® 3D Scaffold for Cell Culture) via its own online storefront; regional distribution through five specialty life-science distributors (AMSBIO in the Americas/Europe, AMS Biotechnology in Europe, Cell & Gene BioSolutions in India, Sciencewerke in Singapore/Malaysia, and Filgen in Japan); and project-based custom non-woven collagen scaffold manufacturing for enterprise tissue-engineering customers. Bespoke co-development engagements include a 'bionic' nerve project with ReNerve and a plant-based recombinant human collagen program with PlantForm Corporation (supported by $1.3M from NGen). Customers are primarily academic and commercial tissue-engineering, 3D bioprinting, and regenerative medicine researchers, with secondary exploration of advanced-materials verticals such as green textiles, aerospace, and defense.

The company is privately held and venture-backed, having raised approximately CAD $8.07M in equity across four rounds (October 2020, September 2021, July 2023, and June 2025) plus CAD $1.5M in non-dilutive grants from ACOA and NGen. Current capital priorities are manufacturing capacity expansion and the construction of a new clean room in Halifax for medical-grade materials production. The 11–50-person organization was recognized as Most Innovative Company at the 2024 Discovery Awards and is positioning for regulated tissue-engineering and regenerative-medicine supply as its manufacturing footprint scales.

Name

3D BioFibR

Legal name

3DBioFibR Inc.

Website

https://3dbiofibr.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

3D BioFibR is a Halifax-based biotech company that uses patented automated dry-spinning technology to manufacture commercial-scale collagen and other biopolymer fibers for tissue engineering, 3D bioprinting, and regenerative medicine researchers worldwide.

Ownership category

akta.pro rank

Product category

Biopolymer Fiber Materials

NAICS

Plastics Material and Resin Manufacturing (325211), Resin and Synthetic Rubber Manufacturing (32521)

SIC

Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)

akta.pro primary industry

Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends) (IMANAAAG)

akta.pro secondary industry

Polymer 3D Printing Service Bureaus (FDM/FFF, SLA/DLP, SLS/MJF) (IMAAADAA)

Keywords

• Biopolymer fiber manufacturing
• Collagen fiber products
• Tissue engineering materials
• Dry-spinning technology
• 3D bioprinting materials

Headquarters

HQ city

Halifax

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Direct product sales via e-commerce storefront: Online storefront at shop.3dbiofibr.com sells CollaFibR tissue engineering products directly to end users, including μCollaFibR™ additive for bioinks and hydrogels and CollaFibR® 3D Scaffold for Cell Culture. Transactional, unit-priced purchases.
2. Distributor-led sales in regional markets: Revenue generated through regional distribution partners (AMSBIO in Americas/Europe, Cell & Gene BioSolutions in India, Sciencewerke in Singapore & Malaysia, Filgen in Japan) reselling CollaFibR products to local research customers.
3. Custom scaffold manufacturing services: Project-based custom non-woven collagen scaffold manufacturing for tissue engineering customers with bespoke specifications, sold directly via the company.
4. Non-dilutive co-development and grant funding: Funding from Next Generation Manufacturing Canada ($1.3M) and ACOA ($200,000) supporting R&D and automation projects. While not core revenue, supports scaling of commercial product offerings.

Pricing tiers

Go-to-market motion4 records

Distribution channels7 records

Marketing channels5 records

Core offering

3D BioFibR manufactures biomimetic collagen fibers and other biopolymer fibers using its patented, fully automated dry-spinning technology, delivering over 1000X the throughput of competing approaches. The company sells its CollaFibR® product family (μCollaFibR™ Additive for Bioinks and Hydrogels and CollaFibR® 3D Scaffold for Cell Culture) directly and via a global distributor network for tissue engineering, 3D bioprinting, and cell culture applications, and offers bespoke Custom Scaffolds and the SpidrFibR™ spider silk prototype.

Product overview

3D BioFibR is a biotech company built around a single patented, fully automated dry-spinning platform that produces biopolymer fibers at commercial scale (over 1000× the throughput of competing technologies). The platform's flagship output is the CollaFibR® family of collagen fibers, which replicate the structure, biomechanics, and biochemical properties of natural collagen. CollaFibR® is commercialized as two catalog SKUs — μCollaFibR™ Additive for Bioinks and Hydrogels and CollaFibR® 3D Scaffold for Cell Culture — sold directly and through a global distributor network (AMSBIO in the Americas/Europe, Cell & Gene BioSolutions in India, Sciencewerke in Singapore/Malaysia, and Filgen in Japan). Beyond collagen, the same dry-spinning platform is used to spin other network-forming biopolymers, exemplified by the SpidrFibR™ recombinant spider silk prototype. Custom non-woven collagen scaffolds for tissue engineering are offered on a made-to-order basis through the Custom Scaffolds line, and the company is collaborating with PlantForm Corporation on plant-based recombinant human collagen fiber production and with ReNerve on a 'bionic' nerve project.

Differentiator

Problem solved

Functional benefit

Brands

• CollaFibR: Patented collagen fiber product line produced using 3DBioFibR's dry-spinning technology, including the μCollaFibR additive for bioinks and hydrogels and the CollaFibR 3D Scaffold for cell culture. Used for 3D bioprinting, hydrogels, and tissue engineering applications.
• SpidrFibR
• μCollaFibR

Products and services

• μCollaFibR™ Additive for Bioinks and Hydrogels 50 μm type I collagen fibers used as an additive for bioinks and hydrogels, universally compatible with bioprinting materials and modalities, chemically stable in solvents with pH >2, and acts as a physiologically relevant site for cell attachment while improving shape fidelity of bioprinted constructs. For tissue engineering and 3D bioprinting researchers.
• CollaFibR® 3D Scaffold for Cell Culture 100 μm porous collagen fiber scaffold resembling natural three-dimensional collagen structures, produced using automated robotics and GMP grade type I collagen (bovine) for high batch-to-batch consistency, provided in user-friendly 12-well plate inserts and compatible with brightfield, epifluorescence, confocal, and live cell microscopy. For tissue engineering researchers.
• SpidrFibR™ Recombinant Spider Silk Recombinant spider silk prototype produced using 3D BioFibR's patented dry-spinning technology, described as five times stronger than steel and more extensible than rubber. Targeted at green textiles, aerospace engineering, and defense applications.
• Custom Scaffolds Bespoke non-woven collagen scaffolds for tissue engineering produced via 3D BioFibR's patented dry-spinning technology, sold directly to clients with project-based specifications.

Quantifiable outcome

• Over 1000X the throughput of competing dry-spinning/collagen technologies
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• PlantForm CorporationcoreStrategic or Co-development Partner · 18 January 2024PlantForm Corporation is a co-development collaborator that received $1.3M from NGen jointly with 3D BioFibR. The project combines PlantForm's plant-based biologics platform with 3D BioFibR's fiber manufacturing technology to produce collagen fibers that mimic natural properties.
• ReNervecoreStrategic or Co-development Partner · 28 June 2023ReNerve and 3D BioFibR partnered for a 'bionic' nerve project to develop nerve repair solutions using CollaFibR collagen fiber technology.
• AMSBIO LLC.coreChannel Partner/ Reseller/ DistributorAMSBIO LLC. is 3D BioFibR's distributor for the Americas, based at 1035 Cambridge Street, Suite 11 B, Cambridge, MA 02141. They resell CollaFibR tissue engineering products via their website (amsbio.com).
• AMS Biotechnology (Europe) Ltd.coreChannel Partner/ Reseller/ DistributorAMS Biotechnology (Europe) Ltd. is 3D BioFibR's European distributor, based at 184 Park Drive, Milton Park, Abingdon OX14 4SE, U.K. They resell CollaFibR products to research customers across Europe.
• Cell & Gene BioSolutionssupportingChannel Partner/ Reseller/ DistributorCell & Gene BioSolutions is 3D BioFibR's distributor in India, based at 418-B Rampriya Brundavan Gardenia, 4th Main, 4th Cross, Hanumgiri, Arehalli, Bangalore-560061, Karnataka, India.
• Sciencewerke Pte LtdsupportingChannel Partner/ Reseller/ DistributorSciencewerke Pte Ltd is 3D BioFibR's distributor for Singapore and Malaysia, based at 102E Pasir Panjang Rd #08-03 Citilink Warehouse Complex, Singapore 118529.
• Filgen Inc.supportingChannel Partner/ Reseller/ DistributorFilgen Inc. is 3D BioFibR's distributor in Japan, based at 02E Pasir Panjan 1-409, Jonoyama, Midori-ku, Nagoya, Aichi-pref. 459-8011, Japan.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Collagen Solutions (Rousselot): Rousselot (which acquired Collagen Solutions) is a global leader in collagen-based solutions for biomedical, pharmaceutical, and food applications. Directly comparable to 3D BioFibR as a supplier of medical-grade collagen materials for tissue engineering and regenerative medicine, but at significantly larger scale with established GMP manufacturing.
• Cellink (BICO Group): BICO/Cellink is a global bioconvergence company providing bioprinters, bioinks, and biomaterials for 3D cell culture and tissue engineering. Comparable to 3D BioFibR as a supplier into the bioprinting workflow, but at much broader portfolio scale and with bioprinter hardware alongside bioinks.
• Collagen Matrix Inc. Collagen Matrix is a U.S. manufacturer of collagen and other natural polymer-based medical devices for tissue repair and regeneration. Comparable to 3D BioFibR as a medical-grade collagen products supplier, but operating at larger scale with established FDA-cleared products.
• DSM Biomedical: DSM Biomedical (part of dsm-firmenich) is a global supplier of biomaterials including collagen, hyaluronic acid, and resorbable polymers for medical devices and tissue engineering. Comparable to 3D BioFibR as a regulated medical-grade biomaterials supplier, but at vastly larger scale and broader portfolio scope.
• Corbion (biomaterials): Corbion is a Dutch biobased ingredients company with biomedical-grade biopolymers used in medical devices and regenerative medicine. Comparable to 3D BioFibR as a biomaterials supplier targeting medical and life-science customers, but at much broader scope and corporate scale.

Direct peers

• Advanced BioMatrix: Advanced BioMatrix is a U.S.-based supplier of collagen, hyaluronic acid, and other extracellular matrix products used in 3D bioprinting, tissue engineering, and cell culture. Directly comparable to 3D BioFibR as a catalog supplier of biomaterials to the same research-tool and tissue-engineering customer base, though without a dry-spinning fiber platform.
• Jellagen Pty Ltd: Jellagen manufactures marine (jellyfish) collagen-based biomaterials for medical devices, 3D cell culture, and tissue engineering. Directly comparable to 3D BioFibR as a specialist collagen supplier targeting the same research and regenerative-medicine segments, with a differentiated raw material source.
• Matricel GmbH: Matricel is a German manufacturer of collagen-based scaffolds and medical devices for tissue engineering and regenerative medicine. Directly comparable to 3D BioFibR as a specialist collagen scaffold producer, though focused on processed collagen matrices rather than spun collagen fibers.
• Spiber Inc. Spiber is a Japanese biotechnology company producing Brewed Protein (recombinant spider silk) materials for textiles, automotive, and other applications. Directly comparable to 3D BioFibR on the SpidrFibR spider silk program — both are working on scalable recombinant spider silk — though Spiber is significantly larger and more commercially advanced in apparel.
• Modern Meadow: Modern Meadow is a U.S. biotech developing bioengineered collagen and other protein-based materials for consumer products and materials applications. Comparable to 3D BioFibR as a bioengineered protein-fiber platform company targeting non-medical and medical markets, with a broader near-term focus on materials/textile applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/3dbiofibr

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds8 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3D BioFibR